|
Drug Therapy, Other
Citations 21-30 of 395 total displayed.
|
Past content
(since Mar 1999):
|
- Editor's Correspondence
ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses—Reply
- Jackson T. Wright Jr; Jeffrey L. Probstfield; William C. Cushman; Sara Pressel; Jeffrey A. Cutler; Barry R. Davis; Paula T. Einhorn; Mahboob Rahman; Paul K. Whelton; Charles E. Ford; L. Julian Haywood; Karen L. Margolis; Suzanne Oparil; Henry R. Black; Michael H. Alderman; for the ALLHAT Collaborative Research Group
Arch Intern Med 2009; 169: 1810-a-1811-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses
- Macaulay A. C. Onuigbo
Arch Intern Med 2009; 169: 1810.
[Extract]
[Full text]
[PDF]
- Commentaries
A Road Map to Control Malaria, Tuberculosis, and Human Immunodeficiency Virus/AIDS
- Thomas R. Frieden; Awash Teklehaimanot; Sekai Chideya; Paul Farmer; Jim Y. Kim; Mario C. Raviglione
Arch Intern Med 2009; 169: 1650-1652.
[Extract]
[Full text]
[PDF]
- Editorials
Can the Food and Drug Administration Ensure That Our Pharmaceuticals Are Safely Manufactured?
- William K. Hubbard
Arch Intern Med 2009; 169: 1655-1656.
[Extract]
[Full text]
[PDF]
- Review Articles
Statins for the Prevention and Treatment of Infections: A Systematic Review and Meta-analysis
- Imad M. Tleyjeh; Tarek Kashour; Fayaz A. Hakim; Valerie A. Zimmerman; Patricia J. Erwin; Alex J. Sutton; Talal Ibrahim
Arch Intern Med 2009; 169: 1658-1667.
[Abstract]
[Full text]
[PDF]
[ eTables ]
- Original Investigations
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter: A Population-Based, Case-Control Study
- Christian Fynbo Christiansen; Steffen Christensen; Frank Mehnert; Steven R. Cummings; Roland D. Chapurlat; Henrik Toft Sørensen
Arch Intern Med 2009; 169: 1677-1683.
[Abstract]
[Full text]
[PDF]
[ eAppendix ]
- Research Letters
Trends in Medication Use Among US Adults With Diabetes Mellitus: Glycemic Control at the Expense of Controlling Cardiovascular Risk Factors
- Devin M. Mann; Mark Woodward; Fen Ye; Marie Krousel-Wood; Paul Muntner
Arch Intern Med 2009; 169: 1718-1720.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Pharmacists Are Key to Enhancing Benefit Risk for Medicines—Reply
- Michael D. Murray
Arch Intern Med 2009; 169: 1723-a-1724-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Pharmacists Are Key to Enhancing Benefit Risk for Medicines
- Anjan K. Banerjee
Arch Intern Med 2009; 169: 1723.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Are We Providers or Physicians?
- J. David Baxter
Arch Intern Med 2009; 169: 1725.
[Extract]
[Full text]
[PDF]
|
|
